The present study indicated that the inhibitory effects of anti-IL-1β antibody on OVA-induced airway inflammation may be mediated by the inhibitory role of anti-IL-1β antibody on the TLR2/MyD88/NF-κB pathway. The gene discussed is IL1B; the disease is inflammatory response.